Stock upgrades by reputable financial institutions like B of A Securities typically lead to an immediate positive reaction in the stock market. The upgrade from Neutral to Buy signals increased confidence in Cellebrite DI's future performance, potentially attracting more investors and driving up the stock price. The set price target of $12 further quantifies the expected upside, providing a tangible goal for investors.